CASI Pharmaceuticals & BioInvent
1,724
20
2023-5-12 15:28
CASI Pharmaceuticals – executive interview – from EDISON
好好的告个别吧~
Iatrogenic Splenic Injury in Colorectal Surgery - Laparoscopic Hemostatic Control
USS脊柱通用系统：脊柱侧弯前路矫正术（T12-L5）
Definitive treatment of pelvic ring injuries - 1 of 3
Experts’ Insights with Dr. Becky Keeble – Common Laparoscopic Services
USS侧开口椎弓根螺钉稳定腰骶椎
Attention deficit hyperactivity disorder (ADHD/ADD) - causes, symptoms & pathology (Updated 2024)
0 bullet chats
Please Sign In first
120101
Scan by WeChatUnauthorized reproduction is prohibited
BioStock interviews BioInvent's CEO Martin Welschof and Wei-Wu He, Chairman & CEO of CASI Pharmaceuticals about their collaboration on BioInvent's propriety asset, the drug candidate and antibody BI-1206.
Comments 0
Please to post a comment~
Loading...
Related Suggestion